# Study of Sorafenib and Docetaxel in Metastatic Prostate Cancer

> **NCT00619996** · PHASE2 · COMPLETED · sponsor: **Italian Trial in Medical Oncology** · enrollment: 43 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** Sorafenib (Nexavar)
- **DRUG:** Docetaxel

## Key facts

- **NCT ID:** NCT00619996
- **Lead sponsor:** Italian Trial in Medical Oncology
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-03
- **Primary completion:** 2008-01
- **Final completion:** 2009-01
- **Target enrollment:** 43 (ESTIMATED)
- **Last updated:** 2009-02-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00619996

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00619996, "Study of Sorafenib and Docetaxel in Metastatic Prostate Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00619996. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*